Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

data integration

4 posts
SSwitzerland
Swiss Proptech Firm Norm Technologies Develops Building Energy Efficiency Management Software to Enhance Building Asset Energy Management Efficiency
Read More

Swiss Proptech Firm Norm Technologies Develops Building Energy Efficiency Management Software to Enhance Building Asset Energy Management Efficiency

  • 2026-06-12
Image source: startupticker The Swiss real estate technology company Norm Technologies was founded in 2022. The company is…
NNovartis
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
Read More

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

  • 2026-06-03
Novartis Pharma AG Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented…
NNovartis
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
Read More

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

  • 2026-05-27
Novartis Pharma AG Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented…
NNovartis
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
Read More

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

  • 2026-05-26
Novartis Pharma AG Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented…
Switzerland
www.europesays.com